vimarsana.com

Latest Breaking News On - Quarter for mirum pharmaceuticals - Page 1 : vimarsana.com

Frazier Life Sciences Management L P Grows Stock Holdings in Mirum Pharmaceuticals, Inc (NASDAQ:MIRM)

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]

Mirum Pharmaceuticals, Inc (NASDAQ:MIRM) Director Sells $128,400 00 in Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) Director Saira Ramasastry sold 5,000 shares of Mirum Pharmaceuticals stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $25.68, for a total value of $128,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]

Mirum Pharmaceuticals, Inc (NASDAQ:MIRM) COO Peter Radovich Sells 4,303 Shares

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 4,303 shares of Mirum Pharmaceuticals stock in a transaction on Monday, March 25th. The stock was sold at an average price of $25.80, for a total transaction of $111,017.40. Following the sale, the chief operating officer now directly owns 29,013 shares of the […]

Mirum Pharmaceuticals, Inc (NASDAQ:MIRM) COO Sells $111,017 40 in Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 4,303 shares of the firm’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $25.80, for a total value of $111,017.40. Following the completion of the transaction, the chief operating officer now owns 29,013 shares […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.